Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen

Universität des Saarlandes58 enrolled

Overview

Questionnaire to measure and control the quality of life of patients with hay fever who are treated or were treated with Pollinex quattro

Questionnaire including 19 questions concerning the Quality of life of patients with hayfeyer under or after therapy with a specific immuntherapy with Pollinex quattro

Study Type

OBSERVATIONAL

Enrollment

Conditions

Rhinitis, Allergic, Seasonal

Interventions

Quality of life under or after therapy with Pollinex quattroOTHER

To measure Quality of life using the DLQI-index in year one, year two, year three or six month after therapy with Pollinex quattro plus.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Pollinosis/seasonal Rhinitis based on an allergy against birch/alder/Hazel pollen OR grass/rye pollen OR mugwort * Therapy with Polinex quattro Exclusion Criteria: * Age \<18 years.

Locations (1)

Saarland University Hospital. Department of Dermatology

Homburg, Saarland, Germany

Outcomes

Primary Outcomes

Quality of life questionnaire (DLQI)

Time frame: during year one, year two, year three of therapy or within 6 months after completion of therapy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.